Daryaee Fereidoon, Kobarfard Farzad, Khalaj Ali, Farnia Parisa
Department of Medicinal Chemistry, Faculty of Pharmacy and Neuroscience Research Center, Kerman University of Medical Science, Kerman, Iran.
Eur J Med Chem. 2009 Jan;44(1):289-95. doi: 10.1016/j.ejmech.2008.02.022. Epub 2008 Mar 7.
On the basis of the structural similarity of N-substituted glycolamides with N-glycolyl muramic acid residues of the cell wall of Mycobacterium tuberculosis, a series of these compounds were designed and synthesized by the reaction of glycolic acid acetonide 1 (2,2-dimethyl-5-oxo-1,3-dioxolane) with the proper amines. The minimum inhibitory concentration (MIC) was determined against M. tuberculosis H(37)Rv in BACTEC 12B medium, using the Microplate Alamar Blue Assay (MABA). Among the synthesized compounds, all those with disubstituted amide structure accompanied by one or two heteroatom(s) with loan pair(s) of electrons atom(s) beta to the amide nitrogen demonstrated moderate anti-tuberculosis activity and all the monosubstituted amides showed no activity at all.
基于N-取代乙醇酰胺与结核分枝杆菌细胞壁中N-糖基化胞壁酸残基的结构相似性,通过乙醇酸丙酮化物1(2,2-二甲基-5-氧代-1,3-二氧戊环)与适当的胺反应,设计并合成了一系列此类化合物。使用微孔板阿拉玛蓝测定法(MABA),在BACTEC 12B培养基中测定了对结核分枝杆菌H(37)Rv的最低抑菌浓度(MIC)。在合成的化合物中,所有具有二取代酰胺结构且在酰胺氮的β位伴有一个或两个带有孤对电子的杂原子的化合物均表现出中等抗结核活性,而所有单取代酰胺均完全没有活性。